BACKGROUND: Interleukin (IL)-17A, a newly identified cytokine, may participate in the transition of a stable plaque into an unstable plaque. Macrophages play a critical role in the destabilization of atherosclerotic plaque. METHODS: RAW 264.7 cells were stimulated with IL-17A. The mRNA expression of inflammatory cytokines was determined by RT-PCR. The cytokines production in the supernatants was measured by ELISA. Small interfering RNA (siRNA) was used to confirm that IL-17A-induced pro-inflammatory cytokines production via IL-17RA signaling. The western blot assay was used to detect the phosphorylation of MAPKinases including p38 and ERK1/2. The DNA binding activity of nuclear factor NF-κB and AP-1 were detected by EMSA. RESULTS: IL-17A induced the production of pro-inflammatory cytokines in macrophages in a time- and dose-dependent manner, such as tumor necrosis factor (TNF)-α, IL-1β, and IL-6. Meanwhile, IL-17A resulted in the phosphorylation of p38 and ERK1/2 and increased DNA-binding activity of NF-κB and AP-1. Pharmacological inhibitors of p38 and ERK1/2 partly attenuated IL-17A-induced TNF-α, IL-1β, and IL-6 production. Either NF-κB inhibitor or AP-1 inhibitor also partly decreased the IL-17A-induced cytokine production. CONCLUSIONS: IL-17A induces pro-inflammatory cytokines production in macrophages via MAPKinases, NF-κB and AP-1 pathway.
BACKGROUND: Interleukin (IL)-17A, a newly identified cytokine, may participate in the transition of a stable plaque into an unstable plaque. Macrophages play a critical role in the destabilization of atherosclerotic plaque. METHODS: RAW 264.7 cells were stimulated with IL-17A. The mRNA expression of inflammatory cytokines was determined by RT-PCR. The cytokines production in the supernatants was measured by ELISA. Small interfering RNA (siRNA) was used to confirm that IL-17A-induced pro-inflammatory cytokines production via IL-17RA signaling. The western blot assay was used to detect the phosphorylation of MAPKinases including p38 and ERK1/2. The DNA binding activity of nuclear factor NF-κB and AP-1 were detected by EMSA. RESULTS:IL-17A induced the production of pro-inflammatory cytokines in macrophages in a time- and dose-dependent manner, such as tumor necrosis factor (TNF)-α, IL-1β, and IL-6. Meanwhile, IL-17A resulted in the phosphorylation of p38 and ERK1/2 and increased DNA-binding activity of NF-κB and AP-1. Pharmacological inhibitors of p38 and ERK1/2 partly attenuated IL-17A-induced TNF-α, IL-1β, and IL-6 production. Either NF-κB inhibitor or AP-1 inhibitor also partly decreased the IL-17A-induced cytokine production. CONCLUSIONS:IL-17A induces pro-inflammatory cytokines production in macrophages via MAPKinases, NF-κB and AP-1 pathway.
Authors: Tatiana M Clemente; Minal Mulye; Anna V Justis; Srinivas Nallandhighal; Tuan M Tran; Stacey D Gilk Journal: Infect Immun Date: 2018-09-21 Impact factor: 3.441
Authors: Astrid Kleber; Sarah Altmeyer; Beate Wolf; Alexander Wolf; Thomas Volk; Tobias Fink; Darius Kubulus Journal: Inflamm Res Date: 2014-10-29 Impact factor: 4.575
Authors: Nicole Hannemann; Shan Cao; Daniel Eriksson; Anne Schnelzer; Jutta Jordan; Martin Eberhardt; Ulrike Schleicher; Jürgen Rech; Andreas Ramming; Steffen Uebe; Arif Ekici; Juan D Cañete; Xiaoxiang Chen; Tobias Bäuerle; Julio Vera; Christian Bogdan; Georg Schett; Aline Bozec Journal: J Clin Invest Date: 2019-04-16 Impact factor: 14.808
Authors: Davide Pisu; Lu Huang; Vipin Narang; Monique Theriault; Gabrielle Lê-Bury; Bernett Lee; Agnes E Lakudzala; David T Mzinza; David V Mhango; Steven C Mitini-Nkhoma; Kondwani C Jambo; Amit Singhal; Henry C Mwandumba; David G Russell Journal: J Exp Med Date: 2021-07-22 Impact factor: 14.307